(Q35554116)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14533815%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

review article

1 reference

title

Bacterial polysaccharides as vaccines--immunity and chemical characterization (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14533815%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

Bacterial Polysaccharides as Vaccines — Immunity and Chemical Characterization (English)

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-1267-7_30

19 March 2024

1 reference

C. J. Lee

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14533815

19 March 2024

L. H. Lee

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14533815

19 March 2024

C. S. Lu

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14533815

19 March 2024

A. Wu

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14533815

19 March 2024

language of work or name

English

0 references

publication date

1 January 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14533815%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

19 December 2019

http://link.springer.com/content/pdf/10.1007/978-1-4615-1267-7_30

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-1267-7_30

Advances in Experimental Medicine and Biology

19 March 2024

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14533815%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

volume

491

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14533815%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

page(s)

453-471

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14533815%20AND%20SRC:MED&resulttype=core&format=json

THE ELABORATION OF SPECIFIC SOLUBLE SUBSTANCE BY PNEUMOCOCCUS DURING GROWTH.

19 December 2019

cites work

1

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-1267-7_30

Serotype distribution of Streptococcus pneumoniae infections among preschool children in the United States, 1978-1994: implications for development of a conjugate vaccine

19 March 2024

3

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-1267-7_30

Pneumococcal disease: prospects for a new generation of vaccines

19 March 2024

4

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-1267-7_30

Epidemiology of Haemophilus influenzae type b infections in the United States.

19 March 2024

5

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-1267-7_30

Cross-reactive antigens and immunity to diseases caused by encapsulated bacteria

19 March 2024

12

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-1267-7_30

Cross-reactions of polysaccharides of staphylococci and streptococci in antipneumococcal and other antisera

19 March 2024

13

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-1267-7_30

Complement in the pathophysiology of human disease

19 March 2024

16

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-1267-7_30

Antigen-specific suppressor T cells respond to recombinant interleukin-2 and other lymphokines

19 March 2024

18

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-1267-7_30

Regulation of magnitude of antibody response to bacterial polysaccharide antigens by thymus-derived lymphocytes.

19 March 2024

19

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-1267-7_30

The immunological development of the human fetus

19 March 2024

20

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-1267-7_30

Studies of human cord blood and adult lymphocyte interactions with in vitro immunoglobulin production

19 March 2024

21

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-1267-7_30

Membrane receptors in the specific transfer of immunoglobulins from mother to young

19 March 2024

22

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-1267-7_30

Impaired immune response to polysaccharides

19 March 2024

23

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-1267-7_30

An immunodeficiency characterized by impaired antibody responses to polysaccharides

19 March 2024

24

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-1267-7_30

Bacterial polysaccharide immune globulin for prophylaxis of acute otitis media in high-risk children

19 March 2024

25

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-1267-7_30

Serogroup Y meningococcal disease in Chicago, 1991-1997

19 March 2024

27

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-1267-7_30

Immunogenicity of group A and group C meningococcal polysaccharides in human infants

19 March 2024

31

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-1267-7_30

Polysaccharide Vaccines of Group A Neisseria meningitidis and Haemophilus influenzae Type b: A Field Trial in Finland

19 March 2024

32

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-1267-7_30

Pediatric Infectious Disease Journal

19 March 2024

33

11

610

SB Black

1992

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-1267-7_30

Decline of Childhood Haemophilus influenzae Type b (Hib) Disease in the Hib Vaccine Era

19 March 2024

34

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-1267-7_30

Development and phase 1 clinical testing of a conjugate vaccine against meningococcus A and C

19 March 2024

36

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-1267-7_30

Immunologic response of man to group B meningococcal polysaccharide vaccines.

19 March 2024

37

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-1267-7_30

Importance of complement source in bactericidal activity of human antibody and murine monoclonal antibody to meningococcal group B polysaccharide.

19 March 2024

41

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-1267-7_30

Helical epitope of the group B meningococcal alpha(2-8)-linked sialic acid polysaccharide

19 March 2024

43

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-1267-7_30

Three-dimensional structural analysis of the group B polysaccharide of Neisseria meningitidis 6275 by two-dimensional NMR: the polysaccharide is suggested to exist in helical conformations in solution

19 March 2024

45

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-1267-7_30

19 March 2024

47

10

133

S Shen

1989

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-1267-7_30

Considerations for Formulating the Second-Generation Pneumococcal Capsular Polysaccharide Vaccine with Emphasis on the Cross-Reactive Types Within Groups

19 March 2024

48

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-1267-7_30

Pneumococcal infection and immunization in children

19 March 2024

49

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-1267-7_30

Truncated Streptococcus pneumoniae PspA molecules elicit cross-protective immunity against pneumococcal challenge in mice

19 March 2024

55

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-1267-7_30

Evaluation of a pentavalent conjugated pneumococcal vaccine in toddlers

19 March 2024

58

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-1267-7_30

Pneumococcal Polysaccharide-Meningococcal Outer Membrane Protein Complex Conjugate Vaccine Is Immunogenic in Infants and Children

19 March 2024

61

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-1267-7_30

Pilot trial of a pentavalent pneumococcal polysaccharide/protein conjugate vaccine in Gambian infants

19 March 2024

62

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-1267-7_30

Immunogenicity of heptavalent pneumococcal conjugate vaccine in infants

19 March 2024

63

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-1267-7_30

Safety and immunogenicity of heptavalent pneumococcal vaccine conjugated to CRM197 in United States infants.

19 March 2024

64

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-1267-7_30

Response to a heptavalent conjugate Streptococcus pneumoniae vaccine in children with recurrent infections who are unresponsive to the polysaccharide vaccine

19 March 2024

65

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-1267-7_30

Pneumococcal vaccines for children: an update

19 March 2024

66

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-1267-7_30

A glycoprotein pneumococcal conjugate vaccine primes for antibody responses to a pneumococcal polysaccharide vaccine in Gambian children

19 March 2024

67

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-1267-7_30

Bacterial meningitis in the United States, 1986: report of a multistate surveillance study. The Bacterial Meningitis Study Group.

19 March 2024

70

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-1267-7_30

Invasive Haemophilus influenzae type b disease in the Oxford region (1985-91)

19 March 2024

72

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-1267-7_30

Comparative trial in infants of four conjugate Haemophilus influenzae type b vaccines

19 March 2024

74

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-1267-7_30

A randomized, prospective field trial of a conjugate vaccine in the protection of infants and young children against invasive Haemophilus influenzae type b disease.

19 March 2024

75

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-1267-7_30

Reduction of oropharyngeal carriage of Haemophilus influenzae type b (Hib) in children immunized with an Hib conjugate vaccine

19 March 2024

76

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-1267-7_30

Decline of Childhood Haemophilus influenzae Type b (Hib) Disease in the Hib Vaccine Era

19 March 2024

77

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-1267-7_30

Reexamination of the protective role of the capsular polysaccharide (Vi antigen) of Salmonella typhi

19 March 2024

79

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-1267-7_30

Clinical and serological responses following primary and booster immunization with Salmonella typhi Vi capsular polysaccharide vaccines

19 March 2024

80

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-1267-7_30

Prevention of typhoid fever in Nepal with the Vi capsular polysaccharide of Salmonella typhi. A preliminary report

19 March 2024

81

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-1267-7_30

Protective activity of Vi capsular polysaccharide vaccine against typhoid fever

19 March 2024

82

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-1267-7_30

Vi capsular polysaccharide-protein conjugates for prevention of typhoid fever. Preparation, characterization, and immunogenicity in laboratory animals

19 March 2024

85

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-1267-7_30

Group B streptococcal vaccines

19 March 2024

87

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-1267-7_30

Group B streptococcal carriage and disease: a 6-year prospective study

19 March 2024

88

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-1267-7_30

Capsular polysaccharides as vaccine candidates

19 March 2024

90

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-1267-7_30

Immunization of pregnant women with a polysaccharide vaccine of group B streptococcus

19 March 2024

92

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-1267-7_30

Immune response to type III group B streptococcal polysaccharide-tetanus toxoid conjugate vaccine

19 March 2024

93

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-1267-7_30

Toxin genotypes and plasmid profiles as determinants of systemic sequelae in Escherichia coli O157:H7 infections

19 March 2024

96

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-1267-7_30

Cattle as reservoir of verotoxin-producing Escherichia coli O157:H7.

19 March 2024

98

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-1267-7_30

A swimming-associated outbreak of hemorrhagic colitis caused by Escherichia coli O157:H7 and Shigella sonnei

19 March 2024

99

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-1267-7_30

Occurrence of serious bacterial infections since introduction of antibacterial agents

19 March 2024

103

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-1267-7_30

Immunochemical relationships between bacteria belonging to two separate families: Pneumococci and Klebsiella

19 March 2024

109

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-1267-7_30

Safety and immunogenicity of a polyvalent Klebsiella capsular polysaccharide vaccine in humans

19 March 2024

110

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-1267-7_30

Correlation between serum IgG-2 concentrations and the antibody response to bacterial polysaccharide antigens

19 March 2024

112

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-1267-7_30

Enzyme-linked immunosorbent assay to evaluate the immunogenicity of a polyvalent Klebsiella capsular polysaccharide vaccine in humans

19 March 2024

114

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-1267-7_30

Safety and immunogenicity of a Pseudomonas aeruginosa O-polysaccharide toxin A conjugate vaccine in humans

19 March 2024

118

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-1267-7_30

19 March 2024

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14533815%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

1 reference